Results 1 to 10 of about 1,008 (172)
JPSCR: Journal of Pharmaceutical Science and Clinical Research, 2023 Skizofrenia merupakan penyakit gangguan otak parah yang membutuhkan terapi dengan waktu lama sehingga meningkatkan beban biaya dan mempengaruhi kualitas hidup.
Fina Aryani +2 more
doaj +2 more sources
One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study. [PDF]
J Clin Psychopharmacol, 2020 Background Remission in schizophrenia is difficult to achieve. Antipsychotic drugs are critical in the treatment of schizophrenia. International guidelines for the pharmacological treatment of schizophrenia recommend a 3-step algorithm with clozapine ...
Drosos P +8 more
europepmc +2 more sources
JPSCR: Journal of Pharmaceutical Science and Clinical Research, 2023 Terapi kombinasi antispikotik digunakan pada pasien skizofrenia untuk meningkatkan efikasi namun berpotensi untuk terjadinya masalah terkait terapi obat akibat dari interaksi.
Sunandar Ihsan +3 more
doaj +2 more sources
Haseki Tıp Bülteni, 2013 Amaç: Parkinson hastalığında tremor hastalığın başlangıç belirtilerinden olup hastalık seyri boyunca hastaların büyük bir kısmında görülür. Levodopa, dopamin agonistleri ilk seçenek tedavi olarak kullanılmaktadır.
Emel Oğuz Akarsu +6 more
semanticscholar +3 more sources
Clozapine withdrawal catatonia refractory to ECT: a case report
Psychiatry and Clinical Psychopharmacology, 2021 Although catatonia is defined as a subtype of schizophrenia it may occur due to various medical conditions. Catatonic states associated with clozapine withdrawal have been described in a few cases.
Cem Cerit +3 more
doaj +1 more source
CYP1A2*1F polymorphism decreases clinical response to clozapine in patients with schizophrenia
Psychiatry and Clinical Psychopharmacology, 2021 Introduction: Genetic polymorphisms of cytochrome P450 (CYP) may predict the treatment response or occurrence of side effects of antipsychotic drugs.
Hakan Balibey +8 more
doaj +1 more source
Clozaphobia: Fear of Prescribers of Clozapine for Treatment of Schizophrenia.
Psychiatry and Clinical Psychopharmacology, 2021 Klozafobi: Şizofreni Tedavisinde Klozapin Yazmaya Karşı Akıldışı Korku
Mesut Cetin
doaj +1 more source
Psychiatry and Clinical Psychopharmacology, 2021 Objective: In this study, we aimed to evaluate of the incidence of leukopenia and agranulocytosis in patients receiving a combination of clozapine and other antipsychotics in clinical practice.
Abdullah Akpinar, Osman Salis
doaj +1 more source
Comorbid Asperger’s syndrome and schizophrenia and use of clozapine
Psychiatry and Clinical Psychopharmacology, 2021 There is a debate concerning comorbid Asperger’s syndrome and schizophrenia which eventually influences patient management. Comorbid schizophrenia with Asperger’s syndrome cases have been mostly treated with risperidone. A 26 year old man with insomnia,
Omer Yanartas +4 more
doaj +1 more source
Prolongation of hyperprolactinemia by clozapine: a case report
Psychiatry and Clinical Psychopharmacology, 2021 Dopamine antagonism by antipsychotic drugs in the mesolimbic pathway leads to their therapeutic effect, while their D2 receptor antagonism in the tuberoinfindibular pathway causes hyperprolactinemia.
Esra Yancar Demir, Aslihan Sayin
doaj +1 more source